Drug class
Thymidine nucleoside analogue antiviral (anti-varicella-zoster)
Mechanism of action
Preferential phosphorylation by virus-encoded VZV thymidine kinase produces active phosphorylated metabolites; the triphosphate acts as an alternative substrate and inhibitor of viral DNA polymerase, suppressing VZV DNA replication.
General use cases
- Early treatment of acute herpes zoster in immunocompetent adults in jurisdictions where brivudine is authorised
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
